FSH receptor binding inhibitor depresses carcinogenesis of ovarian cancer via decreasing levels of K-Ras, c-Myc and FSHR.
FSH receptor binding inhibitor
K-Ras
Oocyte
Ovarian cancer
Signal pathway
c-Myc
Journal
Animal biotechnology
ISSN: 1532-2378
Titre abrégé: Anim Biotechnol
Pays: England
ID NLM: 9011409
Informations de publication
Date de publication:
Feb 2021
Feb 2021
Historique:
pubmed:
29
8
2019
medline:
12
10
2021
entrez:
29
8
2019
Statut:
ppublish
Résumé
The present study aimed to explore FSH receptor binding inhibitor (FRBI) effects on the levels of c-Myc, K-Ras and VEGF related to ovarian cancer, to evaluate the mRNA and protein levels of FSHR in the cumulus-oocyte complex (COCs). COCs were cultured for 24 h in the
Identifiants
pubmed: 31456468
doi: 10.1080/10495398.2019.1656083
doi:
Substances chimiques
Proto-Oncogene Proteins c-myc
0
Receptors, FSH
0
Proto-Oncogene Proteins p21(ras)
EC 3.6.5.2
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM